The DOI matches its Crossref record; 312 of the 321 references it cites were found in a registry or an index.
Allergen injection immunotherapy for seasonal allergic rhinitis
Open accessAbstract
BACKGROUND: Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased worldwide. For patients whose symptoms remain uncontrolled despite medical treatment, allergen injection immunotherapy is advised. An allergen-based treatment may reduce symptoms, the need for medication and modify the natural course of this disease. OBJECTIVES: To evaluate the efficacy and safety of subcutaneous specific allergen immunotherapy, compared with placebo, for reducing symptoms and medication requirements in seasonal allergic rhinitis patients. SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1 2006), MEDLINE (1950 to 2006), EMBASE (1974 to 2006), Pre-MEDLINE, KOREAMED, INDMED, LILACS, PAKMEDINET, Scisearch, mRCT and the National Research Register. The date of the last search was February 2006. SELECTION CRITERIA: All studies identified by the searches were assessed to identify randomised controlled trials involving participants with symptoms of seasonal allergic rhinitis and proven allergen sensitivity, treated with subcutaneous allergen specific immunotherapy or corresponding placebo. DATA COLLECTION AND ANALYSIS: Two independent authors identified all studies reporting double-blind, placebo controlled randomised trials of specific immunotherapy in patients with seasonal allergic rhinitis due to tree, grass or weed pollens. Two authors independently performed quality assessment of studies. Data from identified studies were abstracted onto a standard extraction sheet and subsequently entered into RevMan 4.2.8. Analysis was performed using the Standardised Mean Difference (SMD) method and a random-effects model; P values < 0.05 were considered statistically significant. The primary outcome measures were symptom scores, medication use, quality of life and adverse events. MAIN RESULTS: We retrieved 1111 publications of which 51 satisfied our inclusion criteria. In total there were 2871 participants (1645 active, 1226 placebo), each receiving on average 18 injections. Duration of immunotherapy varied from three days to three years. Symptom score data from 15 trials were suitable for meta-analysis and showed an overall reduction in the immunotherapy group (SMD -0.73 (95% CI -0.97 to -0.50, P < 0.00001)). Medication score data from 13 trials showed an overall reduction in the immunotherapy group (SMD of -0.57 (95% CI -0.82 to -0.33, p<0.00001)). Clinical interpretation of the effect size is difficult. Adrenaline was given in 0.13% (19 of 14085 injections) of those on active treatment and in 0.01% (1 of 8278 injections) of the placebo group for treatment of adverse events. There were no fatalities. AUTHORS' CONCLUSIONS: This review has shown that specific allergen injection immunotherapy in suitably selected patients with seasonal allergic rhinitis results in a significant reduction in symptom scores and medication use. Injection immunotherapy has a known and relatively low risk of severe adverse events. We found no long-term consequences from adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Total symptom score is the main variable in systematic reviews and meta-analyses, both in SCIT [172] and in SLIT in drops [173] or in tablets [174]; therefore, specific data on NO are not usually published [171].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Beasley, R. W. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07302-9 · Cited by 3,794
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R. F., & Malling, H. ‐. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,582
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E., Jacobson, M. R., O'Brien, F., Noble, W. J., Till, S. J., Hamid, Q. A., & Nouri‐Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,371
Self-citationMöller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Flagged first, then by citations
9 of the 321 references couldn’t be matched to a known paper.
Research works printed but not linked: 29
- Brewczynski, 1999, Efficacy and safety of immunotherapy with modified grass pollen allergens. Results of a placebo-controlled study, Allergologie, 22, 411
- Hauser, 1995, Inhibitory effect on migration of inflammatory cells into the nasal mucosa by immunotherapy, Allergo Journal, 4, 164
- Berstein, 2001, Double blind placebo controlled (DBPC) study of grapeseed extract in the treatment of seasonal allergic rhinitis (SAR), Journal of Allergy and Clinical Immunology, 107, S311
- Calderon, 2003, Double blind placebo controlled study of specific immunotherapy (SIT) with Alutard SQ grass pollen for seasonal allergic rhinoconjunctivitis, Allergy and Clinical Immunology International, 1, Abstract No. O-
- Crimi, 2001, A randomised double-blind study of specific immunotherapy (SIT) in patients with seasonal allergic-rhinitis: effects on clinical and inflammatory markers, European Respiratory Journal, 18, 482s
- Egger, 1997, The influence of hypo-sensitisation therapy on the sense of smell in subjects with seasonal allergic rhinitis, Allergologie, 20, 525
- Frankland, 1963, Treatment of hay fever by depot injection (shypyrindene) in allergic conditions. Double blind clinical study, Acta Allergologica, 18, 175
- Kerr, 1964, The treatment of hay fever including a controlled trial of the use of alum precipitate pollen adsorbate, Acta Allergologica, 19, 76
- Kuhn, 1985, Hyposensitization in pollen sensitive children: A 3 year prospective study, Allergologie, 8, 103
- Lindsay-Miller, 1971, Pollen Tyrosine in the treatment of hay fever, Clinical Allergy, 1, 351
- Malling, 2000, Allergen specific immunotherapy for asthma, Ugeskr Laeger, 162 (4), 477
- Manger, 1984, Hyposensitization of hay fever patients with Tyrosin-adsorbed grass and rye pollen allergoid. Clinical and immunological parameters during different dosages with TA Tyrosin-Allergoid Gräserpollen, Allergologie, 7, 222
- Mewes, 1999, Short term immune therapy with ALK7 reduces grass-pollen induces rhinoconjunctivitis symptoms and the specific nasal reactivity is more efficient than a symptomatic standard therapy, Allergologie, 22, 581
- Nolte, 1999, Allergen extracts, dosing, efficacy and safety of immunotherapy, International Review of Allergology and Clinical Immunology, 5 (3), 184
- Osterballe, 1982, Immunotherapy in hay fever with timothy major allergens, Allergy, 37, 8
- Pastorello, 1988, A double blind placebo controlled trial of specific immunotherapy with aluminium hydroxide adsorbed allergoid in grass pollen induced rhinitis, Allergy, 43, 48
- Ricca, 1997, Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects, Allergologia et Immunopathologia (Madrid), 25, 167
- Rozniecka, 1995, The characteristics of pollinosis during the pollen season and the influence of specific immunotherapy. Part II: Cytologic changes and chemotactic activity in nasal lavage, Pneumonologia i Alergologia Polska, 63, 144
- Ruiz, 2001, Safety and efficacy of immunotherapy with a standardized depigmented and glutaraldehyde-polyerized extract of phleum pratense pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Sandstrom, 2001, Xolair is effective in the treatment of seasonal birch pollen allergic rhinitis, Annals of Allergy, Asthma and Immunology, 86, 83
- Stuck, 2001, Birch pollen allergoid plus MPL in short-term immunotherapy, Otolaryngology - Head and Neck Surgery, 125, P199
- Sykora, 2004, Efficacy and safety of specific allergen immunotherapy with standardized depod allergen H-AI depot (pollens), Alergie, 6, 170
- Watanabe, 2003, Successful grass pollen immunotherapy inhibits eosinophil accumulation in the nasal mucosa: role of adhesion molecules and apoptosis [Abstract], Allergy and Clinical Immunology International, 15, Abstract No.O-1
- Williams, 2001, A study to determine the efficacy of a nasally administered rye grass peptide, Ptl-0901, in the treatment of severe seasonal hayfever, Journal of Allergy and Clinical Immunology, 107, S256
- Williams, 2002, Effectiveness of preseasonal allergoid immunotherapy in patients with grass pollen allergy [Abstract], Allergy, 57, 51
- Yariktas, 2002, Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis, Turkish Archives of Otolaryngology, 40, 252
- Frank, 2001, Effectiveness of a pre-seasonal allergoid immunotherapy in patients with seasonal allergic rhinitis due to grass pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Committee of the Safety of Medicine, 1994, Desensitising vaccines: New advice, Current Problems in Pharmacovigilance, 20, 5
- Durham, 1999, Long-term clinical efficacy of grass-pollen immunotherapy, New England Journal of Medicine, 341(7), 468, 10.1056/NEJM199908123410702 · DOI
Cited by
Sorted by citations
Items 601–674 of 674
Allergische Erkrankungen der oberen und unteren Atemwege
Schmid‐Grendelmeier, P. (2008) · Therapeutische Umschau · doi:10.1024/0040-5930.65.3.137
Mathison, R., Morris, K., Davison, J. S., & Befus, A. D. (2008) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152308786847807
Grazax: sublingual immunotherapy for grass pollen allergy
Chaplin, S., & Durham, S. R. (2008) · Prescriber · doi:10.1002/psb.269
Self-citationIndicaciones de inmunoterapia en patología alérgica
Torres, M. J. (2009) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(09)71192-8
Rancé, F. (2011) · EMC - Pediatría · doi:10.1016/s1245-1789(11)71177-5
Extracts from The Cochrane Library
Burton, M. J., Krouse, J. H., & Rosenfeld, R. M. (2011) · Otolaryngology · doi:10.1177/0194599810395355
Quelles avancées en immunothérapie spécifique des maladies allergiques ?
Didier, A. P., Tetu, L., & Prévôt, G. (2008) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(08)74249-7
Are we prescribing too much or too little immunotherapy for children with allergic rhinitis?
Moral, L. (2012) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2012.02.001
Ear-acupressure for allergic rhinitis
Zhang, S. (2011) · RMIT Research Repository (RMIT University Library)
Intranasal phototherapy for allergic rhinitis
McKean, S. A., Vaidyanathan, S., & Gardiner, Q. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008513.pub2
Leukotriene receptor antagonists for rhinosinusitis
Wilson, T., & Phillips, J. S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007808.pub2
Evaluation of a children's pollen immunotherapy service
Fitzsimons, R., Fox, A. T., Holloway, J. A., Kane, P. M., & Roberts, G. C. (2013) · ePrints Soton (University of Southampton)
Inmunoterapia específica para la dermatitis atópica
Vidal, D. (2008) · Piel · doi:10.1016/s0213-9251(08)72310-4
Brożek, J., Bousquet, J., Baena-Cagnani, E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010)
Guideline on allergen-specic immunotherapy in IgE-mediated allergic diseases
Fa, O. L. I. V. E. R. P., & Johannes Gutenberg-University (2014)
ALLERGEN IMMUNOTHERAPY FOR SEASONAL ALLERGIC RHINITIS
Young, T. (2007)
Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-
Didier, A. P., Wahn, U., Horak, F., & Cox, L. (2014)
Árangur afnæmismeðferðar á Íslandi 1977-2006
Ríkarðsson, S. G., Löve, Y. B., Jörgensen, G. H., Gíslason, D., Ludviksson, B. R., & Lúðvíksson, B. R. (2010) · Læknablaðið · doi:10.17992/lbl.2010.0708.306
Novel Allergen Immunotherapy Routes
Klimek, L., Sperl, A., Senti, G., & Kündig, T. M. (2016) · Current Treatment Options in Allergy · doi:10.1007/s40521-016-0071-7
Lasten pistossiedätyshoidot TAYS:ssa v. 2008-2011
Valjakka, E. (2014) · Tampere University Institutional Repository (Tampere University)
Inmunoterapia específica con alérgenos. Una visión desde el siglo XXI
Liste, A. Á., Ortega, J. D., & de Alergia, S. (2014)
Allergie respiratoire chez l'enfant
Rancé, F. (2011) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(11)72490-5
Willer, G., & Menz, G. (2007) · Der Pneumologe · doi:10.1007/s10405-007-0187-3
Overview of the Medical Management of Chronic Rhinosinusitis
Crosby, D. L., & Kennedy, D. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-16724-4_11
Mechanisms of Allergen-Specific Immunotherapy
Song, W. (2012)
Spezifische Immuntherapie (Hyposensibilisierung)
Kleine‐Tebbe, J. (2016) · Springer eBooks · doi:10.1007/978-3-642-37203-2_54
Approach to the Patient with Nose, Sinus, and Ear Disorders
Murr, A. H. (2012) · Goldman's Cecil Medicine · doi:10.1016/b978-1-4377-1604-7.00434-6
Galvin, K., & Bishop, M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3955-5.10006-x
Efficacy and safety of rapid subcutaneous immunotherapy for Japanese cedar pollinosis in children
Kimura, T., Watanabe, M., Akashi, K., & Katsunuma, T. (2016) · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology · doi:10.3388/jspaci.30.635
Update on Allergen Immunotherapy for Allergic Rhinitis: Drops, Tablets, or Shots?
Roxbury, C. R., & Lin, S. Y. (2017) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-017-0159-z
Alonso‐Coello, P., Comas, D. R., Sanabria, A. J., Plaza, V., Miravitlles, M., & Martinez, L. (2016)
Idiopathic Acute Eosinophilic Pneumonia
Olson, A. L. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9194-1_550
Workplace interventions for treating work-related rhinitis and rhinosinusitis
Muhamad, N. A., Bakhtiar, M. F., Mustapha, N., Adon, M. Y., Airaksinen, L. K., Bakon, S. K., Mohamad, Z. A., & Aris, T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011815
RetractedScadding, G. K. (2008) · Elsevier eBooks · doi:10.1016/b978-141603677-7.50018-2
Hooikoorts/allergische rinitis
Hermans, K. E. (2018) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2251-0_97
Virus-like particles in der Prophylaxe und Immuntherapie allergischer Erkrankungen
Klimek, L., Kündig, T. M., Kramer, M. F., Guethoff, S., Jensen‐Jarolim, E., Schmidt‐Weber, C. B., Palomares, Ó., Mohsen, M. O., Jakob, T., & Bachmann, M. F. (2018) · Allergo Journal · doi:10.1007/s15007-018-1763-z
Specifična imunoterapija u liječenju alergijskih bolesti
Turkalj, M. (2010) · Paediatrics Today
Practical Considerations in Management of Allergic Asthma
Hanania, N. A., Stern, J. L., & Looney, R. J. (2019) · Respiratory medicine · doi:10.1007/978-3-030-20812-7_9
Immunotherapy for Allergic Rhinitis
Guvenc, I. A., Cingi, C., & Scadding, G. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-21217-9_36
Delaunay, M., & Didier, A. P. (2019) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(19)30157-0
Joint Practice Parameters on the Management of Allergic Rhinitis
Administrator, S., Caro, R. M., Recto, M. T., Hernandez, J. G., Sumpaico, M. W., Lopa, R. A. B., Castor, M. A. R., Cabungcal, A. C. A., Leon, J. G. D., Carrillo, J. R. C., et al. (2016) · Acta Medica Philippina · doi:10.47895/amp.v50i1.874
Khoshkhui, M., Jabbari, F., Zargar, F. S., Haghi, N. S. M., & Ariaee, N. (2020) · Research Square · doi:10.21203/rs.3.rs-122405/v1
¿Qué hay sobre el uso de inmunoterapia subcutánea alérgeno específico en asma y rinitis alérgica?
Camoirano, J. (2017) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v20i3.6723
Shakhova, N. V., Gordeev, V. V., Bishevskaya, N. K., Сергеевна, А. Т., Петрович, Т. В., & Kharchenko, S. S. (2012) · Russian Journal of Allergy · doi:10.36691/rja707
La justicia en las sociedades contemporáneas
Bennacer, J. M. (2006) · Cuadernos de derecho judicial
Marcot, C., Frederic de, B. L. A. Y., Guilleminault, L., Didier, A. P., de Bonnecaze, G., Magnan, A., de Gabory, L. L. T., Mortuaire, G., Thillay, A., Amat, F., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-76677-0.00011-3
Georgopoulos, R., & Toskala, E. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-16724-4_10
大久保, 公. (2022) · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · doi:10.7248/jjrhi.61.152
Expression, purification and epitope analysis of Pla a 2 allergen from Platanus acerifolia pollen.
Wang, D., Ni, W., Zhou, Y.-J., Huang, W., Cao, M.-D., Meng, L., & Wei, J.-F. (2018) · PubMed · doi:10.3892/mmr.2017.7883
Passalacqua, G., & Durham, S. R. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.068
Self-citationSmith, W. B. (2014) · Australian Prescriber · doi:10.18773/austprescr.2014.035
Zawinell, A., & Schwabe, U. (2017) · Springer eBooks · doi:10.1007/978-3-662-54630-7_10
Zawinell, A., & Schwabe, U. (2013) · Springer eBooks · doi:10.1007/978-3-642-37124-0_7
Leukotriene receptor antagonists for rhinosinusitis
Wilson, T., & Phillips, J. S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007808
Krouse, J. H. (2009) · Springer eBooks · doi:10.1007/978-3-540-74380-4_21
Hermans, K. E. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-1386-0_62
Zawinell, A., & Schwabe, U. (2019) · Springer eBooks · doi:10.1007/978-3-662-59046-1_11
Zawinell, A., & Schwabe, U. (2018) · Springer eBooks · doi:10.1007/978-3-662-57386-0_10
Long-term natural course of patients with seasonal allergic rhinitis
Cakmak, M. E., Kaya, S. B., Bostan, Ö. C., Damadoğlu, E., Karakaya, G., & Kalyoncu, A. F. (2022) · Alergologia Polska - Polish Journal of Allergology · doi:10.5114/pja.2022.116287
Bager, P., Poulsen, G., Wohlfahrt, J., & Melbye, M. (2022) · medRxiv · doi:10.1101/2022.11.16.22282380
大久保, 公. (2022) · Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) · doi:10.3950/jibiinkotokeibu.125.11_1604
Zukunft der In-vivo-Allergiediagnostik in Deutschland
Klimek, L., Buhai, M., Cuevas, M., Becker, S., Wehrmann, W., Schlenter, W. W., & Brehler, R. (2023) · HNO Nachrichten · doi:10.1007/s00060-023-8489-6
Arce-Estrada, G. E., Arce-Estrada, J., Contreras‐Verduzco, F. A., & Espinosa‐Padilla, S. E. (2022) · Alergia, Asma e Inmunología Pediátricas · doi:10.35366/109664
Ott, H., Kopp, M., & Lange, L. (2023) · Springer eBooks · doi:10.1007/978-3-662-62714-3_5
Hooikoorts/allergische rinitis
Boers, S. (2023) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2962-5_100
On the role of allergen-specific IgG subclasses for blocking human basophil activationPreprint
Vogel, M., Thoms, F., Augusto, G. S., & Bachmann, M. F. (2024) · doi:10.22541/au.170671012.27525086/v1
Loprete, J., Montemayor, J., Richardson, R., Rogers, J., Tong, W. W. Y., Zaunders, J. J., & Carr, A. (2024) · doi:10.22541/au.171724288.82777427/v1
Saidxonova, A., & Хабибуллаевна, М. М. (2025) · Medical science of Uzbekistan · doi:10.56121/2181-3612-2025-2-62-69
Akten, H. S. (2026) · İzmir Tıp Fakültesi Dergisi · doi:10.57221/izmirtip.1985670
Raskopf, E., Passamera, S., Klimek, L., Pfaar, O., Neuhof, C., Rybachuk, A., Katzke, N., Sahin, H., Allekotte, S., Mösges, R., et al. (2026) · Clinical and Translational Allergy · doi:10.1002/clt2.70209
Biodegradable particles as vaccine delivery systems
Joshi, V. B., Salem, A. K., Donovan, M. D., Flanagan, D. R., Thorne, P. S., & Stevens, L. L. (2014) · doi:10.17077/etd.q3wwcov7
Metadata
- Authors
- Calderon, M. A., Alves, B., Jacobson, M., Hurwitz, B., Sheikh, A., & Durham, S.
- Affiliations
- Royal Brompton Hospital; Department of Allergy and Respiratory Medicine; Imperial College School of Medicine at the National Heart and Lung Institute London UK SW3 6LY
- Brighton and Hove City Council (GB)
- Imperial College London (GB)
- King's College London (GB)
- University of Edinburgh (GB)
- Royal Brompton Hospital (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-01-24
- Volume
- 2009
- Issue
- 1
- Pages
- CD001936-CD001936
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7017974
- OpenAlex
- W2153011983
- Cited by
- 678
- References
- 321
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 17 · 2023: 20 · 2022: 31 · 2021: 14 · 2020: 19 · 2019: 24 · 2018: 34 · 2017: 38 · 2016: 41 · 2015: 53 · 2014: 51 · 2013: 50 · 2012: 53
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, allergic rhinitis, tree pollen, grass pollen, weed pollen, symptom scores, medication use, quality of life, adverse events, placebo comparison, treatment efficacy and safety, treatment duration, allergen sensitivity, allergen avoidance, allergen desensitization, allergen tolerance
- MeSH terms
- Allergens, Desensitization, Immunologic, Rhinitis, Allergic, Seasonal, Humans, Injections, Subcutaneous, Pollen, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
